脑膜瘤:系统治疗策略的进步
Xiaoling Qiu1, Zuqing Wu1, Haoqun Xie1
1Department of Neurosurgery/Neuro-oncology, Sun Yat-sen University Cancer Center, Guangzhou, China.
Current neurology and neuroscience reports
|October 22, 2025
概括
系统疗法,包括化疗,向药物和免疫疗法,为复发性表膜瘤提供了先进的选择. 建议对联合治疗进行进一步的研究,以改善患者的治疗结果.
科学领域:
- 神经瘤学神经瘤学
- 系统疗法研究系统疗法研究
- 悬垂瘤治疗策略 治疗策略
背景情况:
- 系统治疗对于管理复发性或不完全切除的尾瘤至关重要.
- 不断变化的治疗场景需要对当前的系统治疗方法进行审查.
研究的目的:
- 总结一下近期针对膜瘤的全身疗法的进展.
- 探索分子向疗法,免疫疗法和常规化疗的选择.
- 为了确定潜在的未来治疗策略,为表膜瘤患者.
主要方法:
- 对表膜瘤的全身治疗策略的文献综述.
- 化疗,分子向疗法和免疫疗法研究的分析.
- 临床前和临床试验数据的综合.
主要成果:
- 化疗仍然是复发性表膜瘤的可行选择.
- 铁氨酸激酶抑制剂,表观遗传剂和PARP抑制剂在向治疗中表现有前途.
- 免疫检查点抑制剂和CAR T细胞疗法在免疫治疗中显示出潜力.
结论:
- 化疗是复发性表膜瘤的一种成熟治疗方法.
- 向疗法和免疫疗法对未来的尾瘤治疗具有重大潜力.
- 关于优化和结合向药物和免疫疗法的进一步研究是有必要的.
相关概念视频
02:56Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
01:27Open Angle Glaucoma: Treatment
958
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
958